Phillips L S, Pennisi A J, Belosky D C, Uittenbogaart C, Ettenger R B, Malekzadeh M H, Fine R N
J Clin Endocrinol Metab. 1978 Jan;46(1):165-8. doi: 10.1210/jcem-46-1-165.
Bioassayable serum somatomedin activity could be estimated in uremic subjects only after appropriate correction for increased circulating inorganic sulfate. Somatomedin activity increased after hemodialysis in six of ten patients, possibly due to removal of somatomedin inhibitors.
只有在对循环中无机硫酸盐增加进行适当校正后,才能在尿毒症患者中估计具有生物活性的血清生长调节素活性。十名患者中有六名在血液透析后生长调节素活性增加,这可能是由于生长调节素抑制剂被清除。